Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCorrection: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.AuthorsZhang, Qi; Riley-Gillis, Bridget; Han, Lina; Jia, Yannan; Lodi, Alessia; Zhang, Haijiao; Ganesan, Saravanan; Pan, Rongqing; Konoplev, Sergej N.; Sweeney, Shannon R.; Ryan, Jeremy A.; Jitkova, Yulia; Dunner Jr, Kenneth; Grosskurth, Shaun E.; Vijay, Priyanka; Ghosh, Sujana; Lu, Charles; Ma, Wencai; Kurtz, Stephen; Ruvolo, Vivian R.PublicationSignal Transduction & Targeted Therapy, 2022, Vol 7, Issue 1, p1ISSN2095-9907Publication typeCorrection NoticeDOI10.1038/s41392-022-00958-4